Target Pediatric AML
Together We Can Fund the Cure
tpaml-overlay.jpg

Collaboratively funding the #1 priority research project for young AML patients

Speeding personalized, targeted therapies for pediatric AML (ages 0-35)

With your help, target pediatric aml can...

aaalab3_preview.jpeg

Jumpstart personalized, precision medicine for young AML patients

iStock-636194124.jpg

Create a fundamental shift in how AML is diagnosed, monitored and treated

iStock-686789790.jpg

comprehensively identify the vulnerabilities
of pediatric AML
through collaboration

 
 

TOGETHER, We can overcome pediatric aml.

 
 

Initiative overview

Learn more about Target Pediatric AML's purpose and mission

Get Involved

You can help us get there!

Why age matters

Give to the cause

Goals & Objectives

 
 

Accelerating the “highest potential, greatest-need”, strategic research project can fundamentally change how AML is treated in young patients ages 0-35.

 
 

Did you know?

The vast majority of all AML funding goes to The adult form

Pediatric AML is categorically different

  • A majority of treatments were tested and designed for adult patients with AML, and are passed down to kids.
  • Kids and teens fighting AML often find themselves at the “end of the line” waiting for new, “hand-me-down” therapies designed for older adults.
  • Targeted, personalized treatments are incredibly promising, yet lack necessary funding.

 

Latest Updates

 
Summary Block
This is example content. Double-click here and select a page to feature its content. Learn more
 

WORKING TOGETHER TO GET SOMETHING BIG DONE IN PEDIATRIC AML

Tpaml list of Supporters.jpg